Log in

Syros Pharmaceuticals SEC Filings & 10K Form (NASDAQ:SYRS)

$7.35
+0.03 (+0.41 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$7.03
Now: $7.35
$7.39
50-Day Range
$6.76
MA: $7.62
$9.21
52-Week Range
$4.45
Now: $7.35
$11.93
Volume164,600 shs
Average Volume240,523 shs
Market Capitalization$311.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

SEC Filings

Syros Pharmaceuticals (NASDAQ:SYRS) SEC Filings

DateFilerForm TypeView
02/13/2020
7:51 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
4:14 PM
Nikko Asset Management Americas, Inc. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2020
5:09 AM
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
7:45 AM
BlackRock Inc. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G
01/13/2020
5:11 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
7:14 AM
Alles Mark J (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
7:13 AM
Alles Mark J (Reporting)
Syros Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2019
7:05 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
6:16 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
6:03 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:34 PM
Springhorn Jeremy P. (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
6:41 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
3:02 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
3:01 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2019
7:36 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
7:30 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
5:22 AM
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G
09/06/2019
1:11 PM
Nikko Asset Management Americas, Inc. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G
08/19/2019
3:08 PM
Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
6:01 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2019
6:26 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:18 PM
Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:17 PM
Syros Pharmaceuticals (Issuer)
WIRTH PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:17 PM
Shaw Alice Tsang (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:16 PM
SHARP PHILIP A (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:16 PM
SATO VICKI L (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:15 PM
Nashat Amir (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:15 PM
Fanucci Marsha (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:14 PM
BONNEY MICHAEL W (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:14 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:13 PM
Shaw Alice Tsang (Reporting)
Syros Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2019
3:01 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
12:40 PM
BlackRock Inc. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
05/02/2019
9:51 AM
Syros Pharmaceuticals (Filer)
Form CT ORDER
05/01/2019
5:50 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
7:03 AM
Syros Pharmaceuticals (Filer)
Form DEFA14A
04/25/2019
7:01 AM
Syros Pharmaceuticals (Filer)
Form DEF 14A
04/24/2019
7:31 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
3:37 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
12:26 PM
Flynn James E (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G
04/05/2019
6:03 AM
Syros Pharmaceuticals (Subject)
Form FWP
04/05/2019
6:02 AM
Syros Pharmaceuticals (Subject)
Form FWP
04/04/2019
3:15 PM
Syros Pharmaceuticals (Filer)
Form 424B5
04/04/2019
3:13 PM
Syros Pharmaceuticals (Filer)
Form 424B5
03/14/2019
5:57 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
4:58 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
NELSEN ROBERT (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
8:18 AM
Syros Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2019
5:32 AM
Syros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
2:07 PM
ARCH Venture Fund VII, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
10:32 AM
ARK Investment Management LLC (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G
02/14/2019
5:28 AM
Polaris Partners VII, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13D/A
01/11/2019
4:02 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
5:30 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
7:07 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
10:50 AM
Syros Pharmaceuticals (Filer)
Form CT ORDER
11/15/2018
3:03 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
5:25 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/26/2018
7:31 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2018
4:01 PM
Syros Pharmaceuticals (Filer)
Form 10-Q/A
08/24/2018
4:01 PM
Syros Pharmaceuticals (Filer)
Form 10-Q/A
08/24/2018
4:00 PM
Syros Pharmaceuticals (Filer)
Form 10-K/A
08/07/2018
5:57 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/15/2018
3:30 PM
Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:30 PM
Syros Pharmaceuticals (Issuer)
WIRTH PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:29 PM
SHARP PHILIP A (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:29 PM
SATO VICKI L (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:29 PM
Nashat Amir (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:28 PM
Fanucci Marsha (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:28 PM
BONNEY MICHAEL W (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:24 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
7:51 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
5:49 AM
Syros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2018
6:04 AM
Syros Pharmaceuticals (Filer)
Form DEFA14A
04/26/2018
6:03 AM
Syros Pharmaceuticals (Filer)
Form DEF 14A
03/15/2018
6:55 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2018
4:10 PM
Ferra Joseph J Jr (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2018
4:09 PM
Ferra Joseph J Jr (Reporting)
Syros Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2018
6:44 AM
Syros Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2018
6:30 AM
Syros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2018
6:05 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2018
3:09 PM
Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2018
3:08 PM
Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2018
3:08 PM
Olson Eric R (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2018
3:08 PM
Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
7:52 AM
Flynn James E (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
5:43 PM
AFEYAN NOUBAR (Reporting)
Syros Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/12/2018
11:15 PM
Syros Pharmaceuticals (Filer)
Form EFFECT
02/09/2018
7:52 AM
Syros Pharmaceuticals (Filer)
Form D/A
02/02/2018
3:29 PM
Arch Venture Fund VII LP (Filed by)
Syros Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2018
3:14 PM
Syros Pharmaceuticals (Filer)
Form S-3/A
02/02/2018
3:05 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2018
2:53 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2018
8:24 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2018
3:32 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2018
3:30 PM
Syros Pharmaceuticals (Filer)
Form 424B5
01/19/2018
4:14 PM
Syros Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/17/2018
3:13 PM
Syros Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/12/2018
4:15 PM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2018
7:15 AM
Syros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2017
6:30 PM
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Form 3/A
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: What is a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel